Health and Healthcare

Wednesday's Top Biotech & Medical Stocks

From BioHealth Investor

Biotechnology

PIPEX PHARMACEUTICAL [PPXP.OB] +12.90%
BOSTON LIFE SCIENCES [BLSI] +10.63%
INSMED INC [INSM] +7.58%
CURAGEN CORP [CRGN] +7.25%
IDM PHARMA INC [IDMI] +6.37%

Diagnostic Substances

GENELABS TECH INC [GNLB] +18.18%
ICAGEN, INC. [ICGN] +14.15%
EPICEPT CORPORATION [EPCT] +11.94%
NYMOX PHARM CORP [NYMX] +8.00%
PRESSURE BIOSCIENC [PBIO] +6.40%

Drug Delivery

BIOPROGRESS PLC [BPRG] +8.99%
HOSPIRA INC [HSP] +6.71%
PETMED EXPRESS INC [PETS] +4.12%
BIOVAIL CORP [BVF] +2.88%
SKYEPHARMA PLC [SKYE] +2.70%

Drug Manufacturers

PLANET TECHS INC [PLNT.OB] +75.00%
ADVANCIS PHARMA CP [AVNC] +8.66%
INYX INC [IYXI.OB] +7.76%
ALTAIR NANOTECH INC [ALTI] +6.21%
ACCESS PHARMACEUTICL [ACCP.OB] +5.97%

Medical Appliances & Equipment

THERAGENICS CORP [TGX] +16.18%
CELSION CORP [CLN] +12.72%
ALLIED HEALTHCARE [AHPI] +10.95%
SYNERGETICS USA INC [SURG] +10.93%
SOMANETICS CORP [SMTS] +8.93%

Medical Instruments & Supplies

MEMRY CORPORATION [MRY] +12.82%
OPHTHALMIC IMAGING SYS INC [OISI.OB] +7.66%
ANGEION CORP [ANGN] +7.52%
MICROMED CARDIOVASCU [MMCV.OB] +7.32%
QUANTRX BIOMEDICAL [QTXB.OB] +7.14%

Medical Laboratories & Research

MEDTOX SCIENTFIC INC [MTOX] +7.14%
BIO-REFERENCE LAB [BRLI] +4.52%
BIO-IMAGING TECH [BITI] +4.22%
PSYCHEMEDICS NEW [PMD] +2.20%
ARRAY BIOPHARMA IN [ARRY] +1.12%

http://www.biohealthinvestor.com/

ALERT: Take This Retirement Quiz Now  (Sponsored)

Take the quiz below to get matched with a financial advisor today.

Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.

Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future

Take the retirement quiz right here.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.